Market research
KRMD Repro Med Systems Inc
NASDAQ USD Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 148M
- P/E ratio
- Not available
- Analyst target
- 6.6
- Dividend yield
- Not available
- Beta
- 0.45
Profile
Company facts
- Exchange
- NASDAQ
- Currency
- USD
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- ISIN
- US7599101026
- Market cap
- 148M
- P/E ratio
- Not available
- Analyst target
- 6.6
- Dividend yield
- Not available
- Beta
- 0.45
About
About Repro Med Systems Inc
KORU Medical Systems, Inc. develops, manufactures, and commercializes subcutaneous infusion solutions primarily for the subcutaneous drug delivery market in the United States and internationally. The company offers the FREEDOM infusion systems to deliver therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD), chronic inflammatory demyelinating polyneuropathy (CIDP), secondary immunodeficiency disorder (SIDD), and paroxysmal nocturnal hemoglobinuria (PNH). Its products include the FREEDOM60 Syringe Driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company was formerly known as Repro Med Systems, Inc. and changed its name to KORU Medical Systems, Inc. in March 2022. KORU Medical Systems, Inc. was incorporated in 1980 and is headquartered in Mahwah, New Jersey.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the KRMD discussion.
5 years, 4 months ago
Repro Med Systems, Inc is currently in a long term downtrend where the price is trading 18.9% below its 200 day moving average.
From a valuation standpoint, the stock is 99.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 6.1.
Repro Med Systems, Inc's total revenue sank by 34.8% to $4M since the same quarter in the previous year.
Its net income has dropped by 895.6% to $-799K since the same quarter in the previous year.
Finally, its free cash flow fell by 345.3% to $-2M since the same quarter in the previous year.
Based on the above factors, Repro Med Systems, Inc gets an overall score of 1/5.